Johnson & Johnson

Novavax faces high stakes FDA review this week that will decide the fate of its Covid vaccine in the U.S.
Business

Novavax faces high stakes FDA review this week that will decide the fate of its Covid vaccine in the U.S.

In this photo illustration the Food and Drug Administration (FDA) and Novavax logos are seen behind a medical syringe and vials. Pavlo Gonchar | LightRocket | Getty Images Novavax’s Covid-19 vaccine will face the scrutiny of the Food and Drug Administration’s independent immunization experts this week, a crucial step on the path toward U.S. regulatory […]

Read More
Cramer’s lightning round: I like Lam Research over Taiwan Semiconductor
Business

Cramer’s lightning round: I like Lam Research over Taiwan Semiconductor

Monolithic Power Systems Inc: “It sells at 40 times earnings, and you know I’m not recommending stocks unless they have a reasonable multiple.” Disclosure: Cramer’s Charitable Trust owns shares of Chevron. VIDEO4:0604:06 Cramer’s lightning round: I like Lam Research over Taiwan Semiconductor Source

Read More
These defensive stocks can protect your portfolio from stagflation, Jefferies says
World

These defensive stocks can protect your portfolio from stagflation, Jefferies says

With “slight or modest” economic growth , inflation still at 40-year highs and a slowdown in hiring , the market could be heading for a period of stagflation, and investors should look to defensive stocks to protect their portfolios, according to Jefferies. Investors have been concerned that a recession may be on the horizon, though […]

Read More
Strategists pick their top stocks to beat rising prices and slowing growth — including some they say are ‘extremely cheap’
World

Strategists pick their top stocks to beat rising prices and slowing growth — including some they say are ‘extremely cheap’

The global economy is beset with rising inflation and slowing growth. Here, CNBC Pro sifts through recent research notes to identify strategists’ top stocks in this tricky environment. The U.S. Federal Reserve hiked rates in March for the first time in more than three years, and announced a further 50-basis-point hike earlier this month . […]

Read More
When the market was tanking, these stocks were hitting all-time highs and could go even higher
Health

When the market was tanking, these stocks were hitting all-time highs and could go even higher

While market losses were racking up, this group of stocks was breaking out to all-time highs and looks set for even more gains. The group is Big Pharma. It’s been long viewed as stodgy by investors looking for quicker price gains. Recently, however, as other stocks slid, these companies have become more attractive because of […]

Read More
Investing Club: Here’s how much each company in our portfolio is exposed to China
World

Investing Club: Here’s how much each company in our portfolio is exposed to China

Shanghai and Beijing have retained, if not tightened, many Covid-related restrictions on business and travel. In this picture, workers disinfect a residential community on May 11, 2022, in Beijing, China. Beijing Youth Daily | Visual China Group | Getty Images Source

Read More
We’re selling half of a retail holding to get into an undervalued health care stock
Business

We’re selling half of a retail holding to get into an undervalued health care stock

The high grading of our portfolio continued Wednesday morning, with the moves made on American Eagle Outfitters and Johnson & Johnson. Source

Read More
Novavax confident Covid vaccine will receive FDA authorization in June after delays
Health

Novavax confident Covid vaccine will receive FDA authorization in June after delays

Novavax is confident its Covid-19 vaccine will receive the endorsement of the Food and Drug Administration’s advisory committee early this summer, executives said this week. The FDA committee is scheduled to meet on June 7 to review Novavax’s submission. An endorsement from the committee, which is made up of independent experts, would mean the drug […]

Read More
J&J names Thibaut Mongon, current consumer health leader, as CEO of new spin-off company
Health

J&J names Thibaut Mongon, current consumer health leader, as CEO of new spin-off company

Signage is displayed outside of Johnson & Johnson headquarters in New Brunswick, New Jersey, Aug. 1, 2020. Mark Kauzlarich | Bloomberg | Getty Images Johnson & Johnson on Wednesday announced that the current head and the chief financial officer of its consumer health portfolio will lead the business when it spins off into a separate […]

Read More
These low-volatility funds offer stability when the Dow swings by 1,000 points
Business

These low-volatility funds offer stability when the Dow swings by 1,000 points

One fund also focuses on companies that pay steady dividends. Source

Read More